Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs
Inguinal Hernia
About this trial
This is an interventional treatment trial for Inguinal Hernia
Eligibility Criteria
Inclusion Criteria: - Patients undergoing laparoscopic inguinal hernia repair at the Mount Sinai Hospital Exclusion Criteria: patients who are younger than 18 years old, have a history of chronic opiate usage, liver or kidney disease, pain syndromes, allergy to bupivacaine, are pregnant or are unable to independently give consent
Sites / Locations
- Mount Sinai Hospital
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Placebo
Experimental
Normal Saline: For patients weighing <100 kg, a total of 50 ml ((25 ml on each side of the abdominal wall) will be received. If patients weigh>100 kg, a total of 60 ml (30ml on each side of the abdominal wall) will be received.
0.25% bupivacaine: For patients weighing <100 kg, a total of 50 ml ((25 ml on each side of the abdominal wall) will be received. If patients weigh>100 kg, a total of 60 ml (30ml on each side of the abdominal wall) will be received.